Cardiomyopathy (heart muscle disease)
Cardiomyopathy is a group of diseases of the heart muscle itself. Depending on the type, the muscle may become enlarged, or thicker and stiffer than normal, and in rare cases scar tissue takes the place of muscle. Some people live long, healthy lives with it and some do not know they have it, while in others the heart pumps blood less well, which can bring heart failure, abnormal heart rhythms, heart valve problems or sudden cardiac arrest. Causes include heart attacks, high blood pressure and infections, some types run in families, and in many people no cause is found.
Also called Cardiomyopathies · Myocardiopathy
- Condition
- In this atlas
Overview
Technical summary
MeSH descriptor D009202 (Cardiomyopathies) classifies these diseases by their predominant pathophysiological features, with dilated, hypertrophic and restrictive forms named. MedlinePlus gives arrhythmogenic right ventricular, dilated, hypertrophic and restrictive cardiomyopathy among its other names for the topic. NHLBI says people can have it whatever their sex, race or age, including newborns and children, and names peripartum cardiomyopathy as a type that some women develop around pregnancy. This is the hub page for the types below it in this atlas.
Recognition
NHLBI names echocardiography as the most common test used to diagnose it.
Burden
No burden claims are published.
Claims and evidence
Context People with cardiomyopathy, as described in MeSH, MedlinePlus, MedlinePlus Genetics and NHLBI reference pages
- Recipient
- Recipient not specified
- Population
- People with cardiomyopathy in general. The pages are written for the public or as a vocabulary and give no study population. They describe adults and also say that newborns and children can have cardiomyopathy. The MedlinePlus Genetics pages describe the nonsyndromic forms, which are not explained by other causes and do not affect other parts of the body.
- Care setting
- General health information for the public; no care setting is stated
- Geography
- United States (pages of US government agencies); the MeSH vocabulary is international
- Life stage
- Not limited by age. NHLBI says people of any age can have cardiomyopathy, including newborns and children, and names peripartum cardiomyopathy as a form that affects some women around pregnancy.
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable (descriptive statement)
Eligibility: inclusion criteria not stated; exclusion criteria not stated
- Included
- None stated
- Excluded
- None stated
MedlinePlus describes cardiomyopathy as diseases of the heart muscle that enlarge the muscle or make it thicker and more rigid than normal, and in rare cases replace muscle with scar tissue. It says some people live long, healthy lives with it and some do not know they have it, while in others the heart pumps blood less well, with heart failure, abnormal heart rhythms, heart valve problems and sudden cardiac arrest named as serious complications. It names heart attacks, high blood pressure and infections among the causes, says some types run in families and says that in many people the cause is unknown. The MeSH scope note describes a group of diseases in which the dominant feature is involvement of the cardiac muscle itself, and says they are classified by their predominant pathophysiological features, with dilated, hypertrophic and restrictive forms named. NHLBI adds that people of any sex, race or age can have it, including newborns and children, and names peripartum cardiomyopathy as a type that affects some women around pregnancy. NHLBI also names echocardiography as the most common test.
Applies to Recipient not specified People with cardiomyopathy, as described in MeSH, MedlinePlus, MedlinePlus Genetics and NHLBI reference pages
- Certainty method
- Not assessed
- Limitations
- Patient-education and vocabulary pages from US government sources. They give no study, no size of risk and no population beyond the general public, and they are not clinical guidance. The NHLBI page is cite only here, so its facts are stated in the atlas's own words.
- Last checked
- 2026-10-30
- Next evidence check due
- Not scheduled
Sources and citations (14)
-
Supports MeSH scope note for descriptor D009202 (Cardiomyopathies)
- Locator
- scopeNote.@value
- How it applies
- MeSH scope note of the descriptor Cardiomyopathies.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
e1a13e2517bd6bbc2ddbea446c058b93cc92862f59c47983bc5c77e0780c0d30- Reuse basis
- The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. This copy was fetched on 2026-10-30 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
-
Supports MeSH scope note for descriptor D009202 (Cardiomyopathies)
- Locator
- scopeNote.@value (second sentence)
- How it applies
- How the scope note classifies the diseases.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
e1a13e2517bd6bbc2ddbea446c058b93cc92862f59c47983bc5c77e0780c0d30- Reuse basis
- The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. This copy was fetched on 2026-10-30 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
-
Supports Cardiomyopathy (MedlinePlus health topic)
- Locator
- Summary, para 1, sentence 1
- How it applies
- What cardiomyopathy is.
- Retrieved
- Source effective date
- 2023-11-15
- Source state
- Current
- Version fingerprint
bc06982f46fc85dfca7d30f0f8280a7ec3d65fda74fb4de58046af352fe69cee- Reuse basis
- MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Cardiomyopathy (MedlinePlus health topic)
- Locator
- Summary, para 1, sentence 2
- How it applies
- How the muscle changes.
- Retrieved
- Source effective date
- 2023-11-15
- Source state
- Current
- Version fingerprint
bc06982f46fc85dfca7d30f0f8280a7ec3d65fda74fb4de58046af352fe69cee- Reuse basis
- MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Cardiomyopathy (MedlinePlus health topic)
- Locator
- Summary, para 1, sentence 3
- How it applies
- Scar tissue in rare cases.
- Retrieved
- Source effective date
- 2023-11-15
- Source state
- Current
- Version fingerprint
bc06982f46fc85dfca7d30f0f8280a7ec3d65fda74fb4de58046af352fe69cee- Reuse basis
- MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Cardiomyopathy (MedlinePlus health topic)
- Locator
- Summary, para 2, sentences 1 and 2
- How it applies
- Some people have few or no symptoms.
- Retrieved
- Source effective date
- 2023-11-15
- Source state
- Current
- Version fingerprint
bc06982f46fc85dfca7d30f0f8280a7ec3d65fda74fb4de58046af352fe69cee- Reuse basis
- MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Cardiomyopathy (MedlinePlus health topic)
- Locator
- Summary, para 2, sentence 3
- How it applies
- Reduced pumping.
- Retrieved
- Source effective date
- 2023-11-15
- Source state
- Current
- Version fingerprint
bc06982f46fc85dfca7d30f0f8280a7ec3d65fda74fb4de58046af352fe69cee- Reuse basis
- MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Cardiomyopathy (MedlinePlus health topic)
- Locator
- Summary, para 2, sentence 4 and list
- How it applies
- Complications the page lists.
- Retrieved
- Source effective date
- 2023-11-15
- Source state
- Current
- Version fingerprint
bc06982f46fc85dfca7d30f0f8280a7ec3d65fda74fb4de58046af352fe69cee- Reuse basis
- MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Cardiomyopathy (MedlinePlus health topic)
- Locator
- Summary, para 3, sentence 1
- How it applies
- Causes the page names.
- Retrieved
- Source effective date
- 2023-11-15
- Source state
- Current
- Version fingerprint
bc06982f46fc85dfca7d30f0f8280a7ec3d65fda74fb4de58046af352fe69cee- Reuse basis
- MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Cardiomyopathy (MedlinePlus health topic)
- Locator
- Summary, para 3, sentences 2 and 3
- How it applies
- Inherited types and unknown causes.
- Retrieved
- Source effective date
- 2023-11-15
- Source state
- Current
- Version fingerprint
bc06982f46fc85dfca7d30f0f8280a7ec3d65fda74fb4de58046af352fe69cee- Reuse basis
- MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Cardiomyopathy: What Is Cardiomyopathy? (NHLBI)
- Locator
- Page body, overview, para 2, sentence 1
- How it applies
- People of any sex, race or age.
- Retrieved
- Source effective date
- 2024-12-06
- Source state
- Current
- Version fingerprint
c2ed20f16b2ad939303295d288e727c40a8921e28059ad9d9ae159f46cbd4b60- Reuse basis
- NHLBI web page. The page states no reuse terms and the NIH web policies were not read for this page, so reuse terms are unverified. This atlas treats the page as cite only: the facts are stated in its own words with the citation and link. Only the hash is kept.
-
Supports Cardiomyopathy: What Is Cardiomyopathy? (NHLBI)
- Locator
- Page body, overview, para 2, sentence 3
- How it applies
- Newborns and children.
- Retrieved
- Source effective date
- 2024-12-06
- Source state
- Current
- Version fingerprint
c2ed20f16b2ad939303295d288e727c40a8921e28059ad9d9ae159f46cbd4b60- Reuse basis
- NHLBI web page. The page states no reuse terms and the NIH web policies were not read for this page, so reuse terms are unverified. This atlas treats the page as cite only: the facts are stated in its own words with the citation and link. Only the hash is kept.
-
Supports Cardiomyopathy: What Is Cardiomyopathy? (NHLBI)
- Locator
- Page body, overview, para 2, sentence 4
- How it applies
- Peripartum cardiomyopathy.
- Retrieved
- Source effective date
- 2024-12-06
- Source state
- Current
- Version fingerprint
c2ed20f16b2ad939303295d288e727c40a8921e28059ad9d9ae159f46cbd4b60- Reuse basis
- NHLBI web page. The page states no reuse terms and the NIH web policies were not read for this page, so reuse terms are unverified. This atlas treats the page as cite only: the facts are stated in its own words with the citation and link. Only the hash is kept.
-
Supports Cardiomyopathy: What Is Cardiomyopathy? (NHLBI)
- Locator
- Page body, overview, para 6, sentence 3
- How it applies
- Echocardiography as the most common test.
- Retrieved
- Source effective date
- 2024-12-06
- Source state
- Current
- Version fingerprint
c2ed20f16b2ad939303295d288e727c40a8921e28059ad9d9ae159f46cbd4b60- Reuse basis
- NHLBI web page. The page states no reuse terms and the NIH web policies were not read for this page, so reuse terms are unverified. This atlas treats the page as cite only: the facts are stated in its own words with the citation and link. Only the hash is kept.
Clinical links
Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.
-
Claim, not a settled fact Risk raised by: Cardiotoxicity from cancer treatment
Applies to Recipient not specified People treated for cancer with chemotherapy, targeted therapy, immunotherapy or radiotherapy (narrative review)
Population, setting and follow-up
- People who have had cancer treatment such as chemotherapy, targeted therapy, immunotherapy or radiotherapy, as the review describes them. The review also mentions long-term studies of childhood cancer survivors.
- Cancer treatment and cardio-oncology care, as described in the review.
- Not stated for the review as a whole.
- Adults and children are not separated here. This record makes no statement about pregnancy, newborns or children.
- Gestational age Not reported
- Postnatal age Not reported
MeSH describes cardiotoxicity as damage to the heart or its function after exposure to toxic substances such as chemotherapy drugs, immunotherapy or radiation. A 2025 narrative review (Heart Failure Reviews) says cancer treatments are frequently linked to cardiovascular toxicity with a significant impact on clinical outcomes and well-being, that there is no universally accepted definition of the condition (it is often defined clinically as a reduction in left ventricular ejection fraction), and that the changes can lead to dilated and restrictive cardiomyopathy and can result in heart failure and sudden cardiac death.Limitations. A narrative review and a thesaurus scope note, not a study of how often the damage occurs. The MeSH descriptor is not limited to cancer care. The review gives no risk figures here: its drug names, mechanisms, risk estimates, classification, monitoring and protective strategies are not repeated, and nothing here says who should be monitored or how.
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 109
Record details
- Record id
cardio:cardiomyopathy- Content hash
1398f24c5fb7edbadd702c7675174696db87f2e87560ca4f2eefc48758c6ff1e